Assistant Professor of Oncology, Johns Hopkins University School of Medicine; Assistant Professor of Oncology
Oncology
Dr. Christine L. Hann, MD
|
|
Give Review
Christine L. Hann is an expert in the field of Oncology. He researched medicine at Jefferson Medical College. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Christine Hann is a published doctor as well. He has 32 publications published. The latest was: A monoclonal antibody against KCNK9 K(+) channel extracellular domain inhibits tumour growth and metastasis. He accepts Medicare.
Publications
- Small Cell Lung Cancer: Can recent advances in biology and molecular biology be translated into improved outcomes?
- DNA methylation in small cell lung Cancer defines distinct disease subtypes and correlates with high expression of EZH2.
- Systemic therapy, clinical outcomes, and overall survival in locally advanced or metastatic pulmonary carcinoid: a brief report.
- Bisphosphonamidate Clodronate Prodrug Exhibits Selective Cytotoxic Activity against Melanoma Cell Lines.
- Tumor lysis syndrome in limited-stage small-cell lung Cancer.
- Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung Cancer.
- Poly(?-amino ester) Nanoparticle Delivery of TP53 Has Activity against Small Cell Lung Cancer In Vitro and In Vivo.
- Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung Cancer.
- Notch signaling contributes to lung Cancer clonogenic capacity in vitro but may be circumvented in tumorigenesis in vivo.
- Bisphosphonamidate Clodronate Prodrug Exhibits Potent AntiCancer Activity in Non-Small-Cell Lung Cancer Cells.
- Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors.
- Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung Cancer and other solid tumors.
- Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid Tumors with neuroendocrine features.
- Intratumoral concentrations of imatinib after oral administration in patients with glioblastoma multiforme.
- Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma.
- Inhibition of the hedgehog pathway in advanced basal-cell Carcinoma.
- Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.
- Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells.
- Management of small-cell lung Cancer: incremental changes but hope for the future.
- Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung Cancer.
- Novel systemic therapies for small cell lung Cancer.
- "Who should receive epidermal growth factor receptor inhibitors for non-small cell lung Cancer and when?".
- Second-line Therapy for advanced non-small-cell lung Cancer.
- Synovial sarcoma of the frontal sinus. Case report.
- Images in clinical medicine. Toxic neutrophils in Streptococcus pneumoniae sepsis.
- A monoclonal antibody against KCNK9 K(+) channel extracellular domain inhibits tumour growth and metastasis.
- Erlotinib inhibits growth of a patient-derived chordoma xenograft.
- Glioblastoma multiforme in the Muir-Torre syndrome.
- Fast, hungry and unstable: finding the Achilles'' heel of small-cell lung Cancer.
- The role of vena caval filters in the management of venous thromboembolism.
- Radiotherapy in small-cell lung Cancer.
Schools
Jefferson Medical College Of Thomas Jefferson University Thomas Jefferson University
Johns Hopkins University School Med
University Of Chicago Hosps
Procedures Preformed
- Thoracentesis
Conditions Treated
- Anemia
- Bladder Cancer
- Breast Cancer
- Carcinoma in Situ
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
- Blue Card PPO
- Blue Preferred PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Coventry Health Care of Delaware PPO
- Emblem Health
- First Health (Coventry Health Care) PPO
- Geisinger Health Plan
- Golden Rule
- Choice Care PPO
- Kaiser Permanente
- MedHealthInsurance
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Tricare
- Choice Plus POS
- Navigate HMO
- Options PPO
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Johns Hopkins University -
University of Chicago -
Jefferson Medical College
Hospital
-
Johns Hopkins Bayview Medical Center -
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER | 1336295021 | |
| NPPES Provider LastName | HANN | |
| NPPES Provider FirstName | CHRISTINE | |
| NPPES Provider ZIPCode | 212870019 | |
| NPPES Provider State | MD | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 116.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1336295021 |
| Last Name Of The Provider | HANN |
| First Name Of The Provider | CHRISTINE |
| View All |
Similar Doctors
|
|
Dr. Stephen H. Glasser, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher A. Klebanoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jenny Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Trishna Goswami, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles G. Drake, MD |
|
|
Dr. Heather A. Parsons, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas D. Ross, MD
This Doctor is OpenDoctor Recommended.
|